Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Pain imaging in health and disease — how far have we come?
Petra Schweinhardt, M. Catherine Bushnell
Petra Schweinhardt, M. Catherine Bushnell
Published November 1, 2010
Citation Information: J Clin Invest. 2010;120(11):3788-3797. https://doi.org/10.1172/JCI43498.
View: Text | PDF
Review Series

Pain imaging in health and disease — how far have we come?

  • Text
  • PDF
Abstract

Since modern brain imaging of pain began 20 years ago, networks in the brain related to pain processing and those related to different types of pain modulation, including placebo, have been identified. Functional and anatomical connectivity of these circuits has begun to be analyzed. Imaging in patients suggests that chronic pain is associated with altered function and structural abnormalities in pain modulatory circuits. Moreover, biochemical alterations associated with chronic pain are being identified that provide information on cellular correlates as well as potential mechanisms of structural changes. Data from these brain imaging studies reinforce the idea that chronic pain leads to brain changes that could have functional significance.

Authors

Petra Schweinhardt, M. Catherine Bushnell

×

Figure 4

Localization of gray matter decreases in chronic pain conditions that have been reported for insula (A), ACC (B), and PFC (C) (for references, see text).

Options: View larger image (or click on image) Download as PowerPoint
Localization of gray matter decreases in chronic pain conditions that ha...
Each sphere represents a peak of gray matter decrease. Note that more than one peak per region was included when reported in a study. Coordinates are in MNI standard stereotaxic space. x refers to left-right (negative numbers in the left hemisphere, positive numbers in the right hemisphere). The anterior commissure corresponds to 0 mm in all three directions. In C, gray matter decreases are only depicted if they are located in the PFC, while the yellow volume encompasses all of frontal cortex, including precentral gyrus. Similarly, decreases in supplementary motor area and premotor cortex are not included. The volume for the insula (red) and frontal cortex (yellow) are based on the MNI Structural Atlas (120, 121), thresholded so that every voxel in the volume falls within the respective brain region (insula or frontal cortex) in at least 5% of individuals. The ACC volume (orange) is based on the Harvard-Oxford Cortical Structural Atlas, equally thresholded at 5%. The MNI Structural Atlas and the Harvard-Oxford Cortical Structural Atlas were used as implemented in fslview of the fsl software suite ( http://www.fmrib.ox.ac.uk/fsl). The size of the spheres representing the localization of gray matter decreases is arbitrary.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts